Abrdn Healthcare Investors (NYSE:HQH – Get Free Report) was the target of a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 145,100 shares, an increase of 115.0% from the January 15th total of 67,500 shares. Based on an average daily volume of 244,200 shares, the short-interest ratio is presently 0.6 days.
Hedge Funds Weigh In On Abrdn Healthcare Investors
A number of large investors have recently made changes to their positions in HQH. Raymond James Financial Inc. purchased a new stake in shares of Abrdn Healthcare Investors during the fourth quarter valued at $15,049,000. Penserra Capital Management LLC bought a new stake in Abrdn Healthcare Investors during the 3rd quarter valued at about $16,145,000. Raymond James & Associates boosted its position in Abrdn Healthcare Investors by 79.8% in the 3rd quarter. Raymond James & Associates now owns 355,205 shares of the financial services provider’s stock valued at $6,614,000 after buying an additional 157,618 shares during the period. Wolverine Asset Management LLC bought a new position in Abrdn Healthcare Investors in the 4th quarter worth about $2,196,000. Finally, LPL Financial LLC grew its stake in Abrdn Healthcare Investors by 65.3% in the 4th quarter. LPL Financial LLC now owns 282,020 shares of the financial services provider’s stock worth $4,526,000 after acquiring an additional 111,383 shares in the last quarter. 32.60% of the stock is owned by hedge funds and other institutional investors.
Abrdn Healthcare Investors Stock Performance
NYSE:HQH traded up $0.18 during midday trading on Thursday, hitting $17.86. 171,089 shares of the company traded hands, compared to its average volume of 226,331. The firm’s fifty day moving average is $17.08 and its 200-day moving average is $17.98. Abrdn Healthcare Investors has a 12-month low of $15.76 and a 12-month high of $19.79.
Abrdn Healthcare Investors Cuts Dividend
Abrdn Healthcare Investors Company Profile
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
See Also
- Five stocks we like better than Abrdn Healthcare Investors
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- Why Invest in High-Yield Dividend Stocks?
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Receive News & Ratings for Abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.